The multivalent activity of the tissue factor–thrombin pathway in thrombotic and non-thrombotic disorders as a target for therapeutic intervention

Author： Mitroulis Ioannis   Kambas Konstantinos   Anyfanti Panagiota   Doumas Michael   Ritis Konstantinos  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.15, Iss.1, 2011-01, pp. : 75-89

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tissue factor – a therapeutic target for thrombotic disorders

By Houston Donald S  

Expert Opinion on Therapeutic Targets, Vol. 6, Iss. 2, 2002-04 ,pp. : 159-174

Informa Healthcare

Access to resources Recommend Favorite

Immunophilins and Thrombotic Disorders

By  

Current Medicinal Chemistry, Vol. 18, Iss. 35, 2011-12 ,pp. : 5414-5423

Bentham Science Publishers

Access to resources Recommend Favorite

Homocysteine, Intracellular Signaling and Thrombotic Disorders

By  

Current Medicinal Chemistry, Vol. 17, Iss. 27, 2010-09 ,pp. : 3109-3119

Bentham Science Publishers

Access to resources Recommend Favorite

Tissue factor pathway inhibitor for cardiovascular disorders

By Kaiser B.   Hoppensteadt D.A.   Fareed J.  

Expert Opinion on Emerging Drugs, Vol. 5, Iss. 1, 2000-02 ,pp. : 73-87

Informa Healthcare

Access to resources Recommend Favorite

Desirudin: A Review of its Use in the Management of Thrombotic Disorders

By Matheson A.J.   Goa K.L.  

Drugs, Vol. 60, Iss. 3, 2000-09 ,pp. : 679-700

Adis International

Access to resources Recommend Favorite